2024 November ACSoMP recommendations
Report of the Meeting of the WHO Advisory Committee on Safety of Medicinal Products, 12-14 November 2024
Overview
The Global Advisory Committee on Vaccine Safety (GACVS) was established in 1999, and the Advisory Committee on Safety of Medicinal Products (ACSoMP) was established in 2003, to provide independent, authoritative, scientific advice to the World Health Organization (WHO), respectively, on vaccine and medicine safety issues of global or regional concern.
The 3-day meeting of ACSoMP and GACVS, 12–14 November 2024 included topics specific to vaccine safety, pharmacovigilance issues common to both vaccines and medicines, and topics specific to medicine safety. A summary of the presentations and recommendations from the medicine specific sessions is provided below. A summary of the discussions and recommendations related to vaccine safety and sessions of common interest for pharmacovigilance of both medicines and vaccines are published in the WHO WER.